Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Preclinical efficacy, safety, and immunogenicity of PHH-1... | ResearchHub
Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Preclinical efficacy, safety, and immunogenicity of PHH-1V, a second-generation COVID-19 vaccine candidate based on a novel recombinant RBD fusion heterodimer of SARS-CoV-2.
0
Authors
Antonio Barreiro
52 more
Antonio Barreiro
•
Antoni Prenafeta
50 more
•
Laura Ferrer
Published
December 4, 2021
Paper
Conversation
0
Reviews
0
Bounties
0
Sign in to review
Share your thoughts on this paper...
Best
Supporters
Support the authors with ResearchCoin
Tip RSC
Preprint Server
Topics
Biology
Epidemiology
Medicine
Immunology
Internal Medicine
Show all topics
DOI
10.1101/2021.11.22.469117
License
cc-no
Supporters
Support the authors with ResearchCoin
Tip RSC
Preprint Server
Topics
Biology
Epidemiology
Medicine
Immunology
Internal Medicine
Show all topics
DOI
10.1101/2021.11.22.469117
License
cc-no
